Literature DB >> 31227231

HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP.

Elizabeth A Lane1, Dong Wook Choi2, Luisa Garcia-Haro2, Zebulon G Levine3, Meghan Tedoldi4, Suzanne Walker3, Nika N Danial5.   

Abstract

Carbohydrate response element binding protein (ChREBP) is a key transcriptional regulator of de novo lipogenesis (DNL) in response to carbohydrates and in hepatic steatosis. Mechanisms underlying nutrient modulation of ChREBP are under active investigation. Here we identify host cell factor 1 (HCF-1) as a previously unknown ChREBP-interacting protein that is enriched in liver biopsies of nonalcoholic steatohepatitis (NASH) patients. Biochemical and genetic studies show that HCF-1 is O-GlcNAcylated in response to glucose as a prerequisite for its binding to ChREBP and subsequent recruitment of OGT, ChREBP O-GlcNAcylation, and activation. The HCF-1:ChREBP complex resides at lipogenic gene promoters, where HCF-1 regulates H3K4 trimethylation to prime recruitment of the Jumonji C domain-containing histone demethylase PHF2 for epigenetic activation of these promoters. Overall, these findings define HCF-1's interaction with ChREBP as a previously unappreciated mechanism whereby glucose signals are both relayed to ChREBP and transmitted for epigenetic regulation of lipogenic genes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ChREBP; H3K4 trimethylation; HCF-1; NASH; O-GlcNAcylation; OGT; PHF2; de novo lipogenesis; glucose; hexosamine biosynthesis pathway

Mesh:

Substances:

Year:  2019        PMID: 31227231      PMCID: PMC6744259          DOI: 10.1016/j.molcel.2019.05.019

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  64 in total

1.  Crosstalk between O-GlcNAcylation and proteolytic cleavage regulates the host cell factor-1 maturation pathway.

Authors:  Salima Daou; Nazar Mashtalir; Ian Hammond-Martel; Helen Pak; Helen Yu; Guangchao Sui; Jodi L Vogel; Thomas M Kristie; El Bachir Affar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-01       Impact factor: 11.205

2.  An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database.

Authors:  J K Eng; A L McCormack; J R Yates
Journal:  J Am Soc Mass Spectrom       Date:  1994-11       Impact factor: 3.109

3.  Xylulose 5-phosphate mediates glucose-induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver.

Authors:  Tsutomu Kabashima; Takumi Kawaguchi; Brian E Wadzinski; Kosaku Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

4.  Chicken ovalbumin upstream promoter-transcription factor II, a new partner of the glucose response element of the L-type pyruvate kinase gene, acts as an inhibitor of the glucose response.

Authors:  D Q Lou; M Tannour; L Selig; D Thomas; A Kahn; M Vasseur-Cognet
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

5.  A phospho-BAD BH3 helix activates glucokinase by a mechanism distinct from that of allosteric activators.

Authors:  Benjamin Szlyk; Craig R Braun; Sanda Ljubicic; Elaura Patton; Gregory H Bird; Mayowa A Osundiji; Franz M Matschinsky; Loren D Walensky; Nika N Danial
Journal:  Nat Struct Mol Biol       Date:  2013-12-08       Impact factor: 15.369

Review 6.  Triglyceride Metabolism in the Liver.

Authors:  Michele Alves-Bezerra; David E Cohen
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

7.  The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.

Authors:  Fadila Benhamed; Pierre-Damien Denechaud; Maud Lemoine; Céline Robichon; Marthe Moldes; Justine Bertrand-Michel; Vlad Ratziu; Lawrence Serfaty; Chantal Housset; Jacqueline Capeau; Jean Girard; Hervé Guillou; Catherine Postic
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

8.  Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.

Authors:  Renaud Dentin; Jean-Paul Pégorier; Fadila Benhamed; Fabienne Foufelle; Pascal Ferré; Véronique Fauveau; Mark A Magnuson; Jean Girard; Catherine Postic
Journal:  J Biol Chem       Date:  2004-02-25       Impact factor: 5.157

9.  The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity.

Authors:  Julien Bricambert; Marie-Clotilde Alves-Guerra; Pauline Esteves; Carina Prip-Buus; Justine Bertrand-Michel; Hervé Guillou; Christopher J Chang; Mark N Vander Wal; François Canonne-Hergaux; Philippe Mathurin; Violeta Raverdy; François Pattou; Jean Girard; Catherine Postic; Renaud Dentin
Journal:  Nat Commun       Date:  2018-05-29       Impact factor: 14.919

10.  How the glycosyltransferase OGT catalyzes amide bond cleavage.

Authors:  John Janetzko; Sunia A Trauger; Michael B Lazarus; Suzanne Walker
Journal:  Nat Chem Biol       Date:  2016-09-12       Impact factor: 15.040

View more
  9 in total

Review 1.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

Review 2.  From Food to Genes: Transcriptional Regulation of Metabolism by Lipids and Carbohydrates.

Authors:  Inés Bravo-Ruiz; Miguel Ángel Medina; Beatriz Martínez-Poveda
Journal:  Nutrients       Date:  2021-04-30       Impact factor: 5.717

3.  Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase.

Authors:  Zebulon G Levine; Sarah C Potter; Cassandra M Joiner; George Q Fei; Behnam Nabet; Matthew Sonnett; Natasha E Zachara; Nathanael S Gray; Joao A Paulo; Suzanne Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-26       Impact factor: 12.779

Review 4.  ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue.

Authors:  Katsumi Iizuka; Ken Takao; Daisuke Yabe
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-03       Impact factor: 5.555

Review 5.  O-GlcNAc: Regulator of Signaling and Epigenetics Linked to X-linked Intellectual Disability.

Authors:  Daniel Konzman; Lara K Abramowitz; Agata Steenackers; Mana Mohan Mukherjee; Hyun-Jin Na; John A Hanover
Journal:  Front Genet       Date:  2020-11-23       Impact factor: 4.599

6.  The Influence of Epigenetic Modifications on Metabolic Changes in White Adipose Tissue and Liver and Their Potential Impact in Exercise.

Authors:  Jessie E Axsom; Heath D Schmidt; Lea Ann Matura; Joseph R Libonati
Journal:  Front Physiol       Date:  2021-08-26       Impact factor: 4.566

Review 7.  Epigenetics in inflammatory liver diseases: A clinical perspective (Review).

Authors:  Teodora Isac; Sebastian Isac; Razvan Rababoc; Mihail Cotorogea; Laura Iliescu
Journal:  Exp Ther Med       Date:  2022-04-04       Impact factor: 2.751

8.  Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure.

Authors:  Liora S Katz; Gabriel Brill; Pili Zhang; Anil Kumar; Sharon Baumel-Alterzon; Lee B Honig; Nicolás Gómez-Banoy; Esra Karakose; Marius Tanase; Ludivine Doridot; Alexandra Alvarsson; Bennett Davenport; Peng Wang; Luca Lambertini; Sarah A Stanley; Dirk Homann; Andrew F Stewart; James C Lo; Mark A Herman; Adolfo Garcia-Ocaña; Donald K Scott
Journal:  Nat Commun       Date:  2022-07-30       Impact factor: 17.694

Review 9.  Glucose-Sensing Transcription Factor MondoA/ChREBP as Targets for Type 2 Diabetes: Opportunities and Challenges.

Authors:  Ziyi Song; Hao Yang; Lei Zhou; Fajun Yang
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.